Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D07PNA
|
|||
Former ID |
DNC006486
|
|||
Drug Name |
2-nonylamido-5-sulfonamidoindane
|
|||
Synonyms |
CHEMBL208532; 2-nonylamido-5-sulfonamidoindane; N-(5-sulfamoyl-2,3-dihydro-1H-inden-2-yl)decanamide; Indanesulfonamide Derivative 12g
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
Structure |
Download2D MOL |
|||
Formula |
C19H30N2O3S
|
|||
Canonical SMILES |
CCCCCCCCCC(=O)NC1CC2=C(C1)C=C(C=C2)S(=O)(=O)N
|
|||
InChI |
1S/C19H30N2O3S/c1-2-3-4-5-6-7-8-9-19(22)21-17-12-15-10-11-18(25(20,23)24)14-16(15)13-17/h10-11,14,17H,2-9,12-13H2,1H3,(H,21,22)(H2,20,23,24)
|
|||
InChIKey |
CWOKTKYGRFERNA-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
References | Top | |||
---|---|---|---|---|
REF 1 | Indanesulfonamides as carbonic anhydrase inhibitors. Toward structure-based design of selective inhibitors of the tumor-associated isozyme CA IX. J Med Chem. 2006 May 4;49(9):2743-9. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.